School project · Delayed data · Not financial adviceTerms
SingularityViewAll companies

Stock research

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. CRL

Healthcare · Diagnostics & Research

$301.79last close 2026-10-09 · market cap $14.41B · delayed data

Trailing returns

1M+8.42%
3M+29.19%
6M+71.91%
1Y+75.32%
5Y-26.24%

Basis: Adjusted daily closes.

What it does

Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. The Research Models and Services segment produces and sells rodents, and purpose-bred rats and mice for use by researchers.

Open CRL in the live terminal →

Valuation, cost of capital, SEC filings, ownership and more, with the source named on every figure.

Post on XLinkedInEmail

Where these figures come from

Delayed data. Not financial advice. Figures are read from the sources above at the dates shown; nothing here is a recommendation. Disclosures · All companies